These investigators assessed common comorbidities and medications in patients of various ages with urticaria and found age-specific differences.
A new international study reports that awareness of patient-reported outcome measures is limited among healthcare providers who treat patients with atopic dermatitis and chronic urticaria. It’s surprising and concerning.
While second-generation H1-antihistamines are standard therapy for both acute and chronic urticaria, some patients need additional treatment to find relief. A new study investigates whether short-course systemic corticosteroids are the answer.
A recent study showed that up to one-third of patients with chronic spontaneous urticaria had non-skin-related symptoms, and these are tied to increased disease activity, poorer disease control, and poorer quality of life.
German investigators conducted an analysis of the patient experience in chronic spontaneous urticaria, identifying pitfalls and suggesting ways to improve care.
It’s not the kind of selfie that first comes to mind, but for patients with symptoms of chronic urticaria, photos of skin lesions taken with their smartphone before a first visit are valuable for treating clinicians, say the results of this report.
The impact of skin diseases is not well understood in the general population among those who forgo clinical consultation. Approximately half of participants with one or more skin disease reported the condition to be quite or very embarrassing in both personal and work life, according to a large population-based survey.
Without clear guidelines and diagnostic criteria, clinicians have often been flying blind in attempting to distinguish between urticarial vasculitis (UV) and chronic spontaneous urticaria (CSU). A task force was convened to help clear up some of the confusion.
A new 5-principle “charter” created by patients, clinicians, and advocacy organizations may be a valuable roadmap for improving care of individuals with chronic urticaria (CU).
Chronic spontaneous urticaria, with and without comorbid chronic inducible urticaria, has clinical and laboratory differences that can help to guide personalized care for patients with these diseases. Here’s what clinicians need to know.